ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,891, issued on Nov. 11, was assigned to KYOWA KIRIN Co. LTD. (Tokyo).
"Bispecific antibody binding to CD40 and GPC3" was invented by Yoshiki Sumitomo (Tokyo) and Masayuki Kai (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide a bispecific antibody including an antigen binding domain that binds to CD40 and an antigen binding domain that binds to GPC3. The present invention relates to a bispecific antibody including an antigen binding domain that binds to CD40 and an antigen binding domain that binds to GPC3, a bispecific antibody fragment thereof, a DNA encoding the bispecific antibody or the bispec...